Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings

M. A. Angulo; M. G. Butler; M. E. Cataletto

doi:10.1007/s40618-015-0312-9

journal article Open Access Jun 11, 2015

Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings

M. A. Angulo M. G. Butler M. E. Cataletto

Journal of Endocrinological Investigation Vol. 38 No. 12 pp. 1249-1263 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s40618-015-0312-9

Topics

No keywords indexed for this article. Browse by subject →

References

146

[1]

Prader A, Labhart A, Willi H (1956) Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im neugeborenenalter. Schweiz Med Wochenschr 86:1260–1261

[2]

Bittel DC, Butler MG (2005) Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 7(14):1–20 10.1017/s1462399405009531

[3]

Butler MG, Lee PDK, Whitman BY (2006) Management of Prader-Willi Syndrome. Springer, New York 10.1007/978-0-387-33536-0

[4]

Butler MG (2011) Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics 12:204–215 10.2174/138920211795677877

[5]

Prader-Willi syndrome

Suzanne B. Cassidy, Stuart Schwartz, Jennifer L. Miller et al.

Genetics in Medicine 2012 10.1038/gim.0b013e31822bead0

[6]

Aycan Z, Bas VN (2014) Prader-Willi syndrome and growth hormone deficiency. J Clin Res Pediatr Endocrinol 6(2):62–67 10.4274/jcrpe.1228

[7]

Buiting K (2010) Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet 154C:365–376 10.1002/ajmg.c.30273

[8]

Williams CA, Driscoll DJ, Dagli AI (2010) Clinical and genetic aspects of Angelman syndrome. Genet Med 12(7):385–395 10.1097/gim.0b013e3181def138

[9]

Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M (1989) Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 342(6247):281–285 10.1038/342281a0

[10]

Nicholls RD, Knepper JL (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Ann Rev Genomics Hum Genet 2:153–175 10.1146/annurev.genom.2.1.153

[11]

Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B (2003) Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet 72(3):571–577 10.1086/367926

[12]

Butler MG, Thompson T (2000) Prader-Willi syndrome: clinical and genetic finding. Endocrinology 10:3S–16S 10.1097/00019616-200010041-00002

[13]

Butler MG (1990) Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 35(3):319–332 10.1002/ajmg.1320350306

[14]

Sun Y, Nicholls RD, Butler MG, Saitoh S, Hainline BE, Palmer CG (1996) Breakage in the SNRPN locus in a balanced 46, XY, t(15;19) Prader-Willi syndrome patient. Hum Mol Genet 5(4):517–524 10.1093/hmg/5.4.517

[15]

Butler MG, Christian SL, Kubota T, Ledbetter DH (1996) A 5-year-old white girl with Prader-Willi syndrome and a submicroscopic deletion of chromosome 15q11q13. Am J Med Genet 65(2):137–141 10.1002/(sici)1096-8628(19961016)65:2<137::aid-ajmg11>3.0.co;2-r

[16]

Kim SJ, Miller JL, Kuipers PJ, German JR, Beaudet AL, Sahoo T, Driscoll DJ (2012) Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet 20(3):283–290 10.1038/ejhg.2011.187

[17]

Rocha CF, Paiva CL (2014) Prader-Willi-like phenotypes: a systematic review of their chromosomal abnormalities. Genet Mol Res 1:2290–2298 10.4238/2014.march.31.9

[18]

Butler MG (2009) Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet 26(9–10):477–486 10.1007/s10815-009-9353-3

[19]

Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91(2):398–402 10.1542/peds.91.2.398

[20]

Gunay-Aygun M, Schwartz S, Heeger S, O’Riordan MA, Cassidy SB (2001) The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 108(5):E92 10.1542/peds.108.5.e92

[21]

Bittel DC, Kibiryeva N, Butler MG (2007) Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Genet Test 11(4):467–475 10.1089/gte.2007.0061

[22]

Henkhaus RS, Kim SJ, Kimonis VE, Gold JA, Dykens EM, Driscoll DJ, Butler MG (2012) Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome. Genet Test Mol Biomarkers 16(3):178–186 10.1089/gtmb.2011.0115

[23]

Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, Dykens E, Butler MG, Shuster JJ, Driscoll DJ (2011) Nutritional phases in Prader-Willi syndrome. Am J Med Genet A 155(5):1040–1049 10.1002/ajmg.a.33951

[24]

Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS (2002) Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat Med 8(7):643–644 10.1038/nm0702-643

[25]

Del Parigi A, Tschöp M, Heiman ML, Salbe AD, Vozarova B, Sell SM, Bunt JC, Tataranni PA (2002) High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87:5461–5464 10.1210/jc.2002-020871

[26]

Tan TM-M, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP (2004) Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 89(8):4162–4165 10.1210/jc.2004-0835

[27]

De Waele K, Ishkanian SL, Bogarin R, Miranda CA, Ghatei MA, Bloom SR, Pacaud D, Chanoine JP (2008) Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. Eur J Endocrinol 159(4):381–388 10.1530/eje-08-0462

[28]

Kweh FA, Miller JL, Sulsona CR, Wasserfall C, Atkinson M, Shuster JJ, Goldstone AP, Driscoll DJ (2015) Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. Am J Med Genet A 167(1):69–79 10.1002/ajmg.a.36810

[29]

Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T (2002) Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med and Child Neurol 44(4):248–255 10.1017/s001216220100202x

[30]

Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M (2011) The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab 96:E225–E232 10.1210/jc.2010-1733

[31]

Diene G, Mimoun E, Feigerlova E et al (2010) French Reference Centre for PWS. Endocrine disorders in children with Prader-Willi syndrome–data from 142 children of the French database. Horm Res Paediatr 74:121–128 10.1159/000313377

[32]

Waterland RA, Jirtle RL (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20(1):63–68 10.1016/j.nut.2003.09.011

[33]

Bittel DC, Kibiryeva N, Talebizadeh Z, Butler MG (2003) Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet 40(8):568–574 10.1136/jmg.40.8.568

[34]

Bittel DC, Kibiryeva N, Talebizadeh Z, Driscoll DJ, Butler MG (2005) Microarray analysis of gene/transcript expression in Angelman syndrome: deletion versus UPD. Genomics 85(1):85–91 10.1016/j.ygeno.2004.10.010

[35]

Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, Person RE, Garnica A, Cheung SW, Beaudet AL (2008) Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40(6):719–721 10.1038/ng.158

[36]

de Smith AJ, Purmann C, Walters RG, Ellis RJ, Holder SE, Van Haelst MM, Brady AF, Fairbrother UL, Dattani M, Keogh JM, Henning E, Yeo GS, O’Rahilly S, Froguel P, Farooqi IS, Blakemore AI (2009) A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet 18(17):3257–3265 10.1093/hmg/ddp263

[37]

Bieth E, Eddiry S, Gaston V, Lorenzini F, Buffet A, Conte Auriol F, Molinas C, Cailley D, Rooryck C, Arveiler B, Cavaille J, Salles JP, Tauber M (2015) Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi syndrome. Eur J Hum Genet 23(2):252–255 10.1038/ejhg.2014.103

[38]

Kishore S, Stamm S (2006) The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311(5758):230–232 10.1126/science.1118265

[39]

Schaaf CP, Gonzalez-Garay ML, Xia F, Potocki L, Gripp KW, Zhang B, Peters BA, McElwain MA, Drmanac R, Beaudet AL, Caskey CT, Yang Y (2013) Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism. Nat Genet 45(11):1405–1408 10.1038/ng.2776

[40]

Macedo DB, Abreu AP, Reis AC, Montenegro LR, Dauber A, Beneduzzi D, Cukier P, Silveira LF, Teles MG, Carroll RS, Junior GG, Filho GG, Gucev Z, Arnhold IJ, de Castro M, Moreira AC, Martinelli CE Jr, Hirschhorn JN, Mendonca BB, Brito VN, Antonini SR, Kaiser UB, Latronico AC (2014) Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3. J Clin Endocrinol Metab 99(6):E1097–E1103 10.1210/jc.2013-3126

[41]

Buiting K, Nazlican H, Galetzka D, Wawrzik M, Gross S, Horsthemke B (2007) C15orf2 and a novel noncoding transcript from the Prader-Willi/Angelman syndrome region show monoallelic expression in fetal brain. Genomics 89(5):588–595 10.1016/j.ygeno.2006.12.008

[42]

Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J, Yavor A, Eichler EE, Nicholls RD (2003) Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 73(4):898–925 10.1086/378816

[43]

Butler MG (1989) Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome. Am J Hum Genet 45(1):140–146

[44]

Butler MG, Fischer W, Kibiryeva N, Bittel DC (2008) Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet Part A 146A(7):854–860 10.1002/ajmg.a.32249

[45]

Bittel DC, Kibiryeva N, Butler MG (2006) Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics 118(4):e1276–e1283 10.1542/peds.2006-0424

[46]

Svenstrup K, Moller RS, Christensen J, Budtz-Jorgensen E, Gilling M, Nielsen JE (2011) NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy. Eur J Neurol 18(9):1197–1199 10.1111/j.1468-1331.2011.03359.x

[47]

Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, Gadi IK, Keitges E, Jaswaney VL, Papenhausen PR, Potluri VR, Risheg H, Rush B, Smith JL, Schwartz S, Tepperberg JH, Butler MG (2011) Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 130(4):517–528 10.1007/s00439-011-0970-4

[48]

Jerkovich AM, Butler MG (2014) Further phenotypic expansion of 15q11.2 BP1-BP2 microdeletion (Burnside-Butler) syndrome. J Ped Genet 3(1):41–44 10.3233/pge-14082

[49]

Cox DM, Butler MG (2015) The 15q11.2 BP1-BP2 microdeletion syndrome: a review. Int J Mol Sci 16(2):4068–4082 10.3390/ijms16024068

[50]

Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T (2004) Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 113:565–573 10.1542/peds.113.3.565

Showing 50 of 146 references

Cited By

490

Hypercoagulability in Prader-Willi Syndrome: A case-control study exploring coagulation profiles and thrombotic risk

Griselda Vallès-Cardona, Assumpta Caixas · 2026

Genetics in Medicine

Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks

Juliette Jacquot-Thierry, Sarah Chalopin · 2025

Diabetes & Metabolism

Molecular Insights into Neurological Regression with a Focus on Rett Syndrome—A Narrative Review

Jatinder Singh, Paramala Santosh · 2025

International Journal of Molecular...

Acts of appetite: neural circuits governing the appetitive, consummatory, and terminating phases of feeding

Ivan C. Alcantara, Ana Pamela Miranda Tapia · 2022

Nature Metabolism

Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells

Wei-Kai Huang, Samuel Zheng Hao Wong · 2021

Cell Stem Cell

Current paradigms in the etiology of obesity

Hoda C. Kadouh, Andres Acosta · 2017

Techniques in Gastrointestinal Endo...

Metrics

490

Citations

146

References

Details

Published: Jun 11, 2015
Vol/Issue: 38(12)
Pages: 1249-1263
License: View

Authors

Cite This Article

M. A. Angulo, M. G. Butler, M. E. Cataletto (2015). Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. Journal of Endocrinological Investigation, 38(12), 1249-1263. https://doi.org/10.1007/s40618-015-0312-9

Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings

You May Also Like